Literature DB >> 9414165

Kaposi's sarcoma and Kaposi's sarcoma associated herpesvirus (human herpesvirus 8): where are we now?

Y Chang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9414165     DOI： 10.1093/jnci/89.24.1829

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

1.  Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.

Authors:  Subhash C Verma; Ke Lan; Tathagata Choudhuri; Erle S Robertson
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

2.  Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus.

Authors:  Subhash C Verma; Bharat G Bajaj; Qiliang Cai; Huaxin Si; Todd Seelhammer; Erle S Robertson
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

3.  The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner.

Authors:  Subhash C Verma; Tathagata Choudhuri; Erle S Robertson
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.